RxDoctor Payments Data

Joshua Sommovilla, MD

Surgery · Cleveland, OHNPI 1669783452

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (43.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Intuitive Surgical at 59.2% of the total. 2025 is the largest year on record at $7,000, more than ten times the $202 reported in 2019.

$9,453in general payments, 2019–2025

Across 55 payments — averaging $171.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$6K
  • Medtronic$630
  • Johnson & Johnson$561
  • Myriad Genetic Laboratories, Inc.$440
  • Aroa Biosurgery Incorporated$403
  • Kerecis Limited$384
  • plus $1K from 9 others

What the payments were for

  • Travel & lodging$1,30414%
  • Food & beverage$4,14944%
  • Education$4,00042%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,453 in reported general payments places this provider in the 80th percentile of 988 surgery providers in Ohio.

See all surgery providers in Ohio →

Medicare billing

Part B allowed, 2024
$82,704
Medicare patients
163
Services billed
337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl55$761
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl15$245
Neomycin Sulfate61$219
Sulindac15$199
Metronidazole61$62

Paid to pharmacies, not to this prescriber.

Other surgery in Cleveland

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →